Brief: Calliditas Therapeutics Q4 Operating Income Rises To SEK 41.8 Million
Feb 21 (Reuters) - Calliditas Therapeutics AB
CALTX.ST :
* Q4 NET SALES AMOUNTED TO SEK 451.6 MILLION VERSUS SEK SEK
429.0
MILLION YEAR AGO
* Q4 OPERATING INCOME AMOUNTED TO SEK 41.8 MILLION AND SEK
32.5
MILLION YEAR AGO
Source text for Eikon: ID:nPn8MsJzda
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations